Filter
287
Filtered Results: 287
Text search:
FDA
US
Food
&
Drug
Administration
Featured
Recommendations
27
New Publications
64
Language
Document type
No document type
159
Guidelines
56
Studies & Reports
43
Manuals
12
Fact sheets
8
Strategic & Response Plan
3
Training Material
2
Resource Platforms
2
Brochures
1
Situation Updates
1
Countries / Regions
India
13
Myanmar / Burma
8
Philippines
7
Russia
7
Ghana
6
USA
6
Western and Central Europe
5
Global
4
Latin America and the Carribbean
4
Uganda
4
South Sudan
4
Thailand
3
Syria
3
Nigeria
3
Germany
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
South Africa
3
Nepal
2
Rwanda
2
Africa
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Angola
2
Tajikistan
1
Sierra Leone
1
Singapore
1
Senegal
1
Peru
1
Mozambique
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Paraguay
1
Argentina
1
Brazil
1
Namibia
1
Sudan
1
Botswana
1
Indonesia
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
53
Pharmacy & Technologies
9
Public Health
8
Women & Child Health
6
Key Resources
5
Capacity Building
3
Toolboxes
COVID-19
37
Mental Health
32
TB
30
HIV
29
AMR
22
Pharmacy
15
Ebola & Marburg
13
Specific Hazards
9
NTDs
8
NCDs
7
Rapid Response
5
Planetary Health
5
Refugee
4
Cholera
2
Conflict
2
Zika
2
Natural Hazards
1
Disability
1
Caregiver
1
Health Financing Toolbox
1
Global Health Education
1
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
The document provides a detailed overview of cholera, including its clinical features, diagnosis, treatment, and prevention. It explains the causes of cholera, its symptoms such as severe diarrhea and dehydration, and the importance of rehydration therapy (oral or intravenous) to reduce mortality. T...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
Menthol in tobacco products
HIV/AIDS Programme
Economic Issues, Policies and Option for Action
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Mood disorders
Chapter E.2
